Researchers combined deep learning and molecular dynamics simulations to re-engineer CD27, the natural binding partner of the pan-cancer target CD70, for use in chimeric antigen receptor (CAR) T-cell therapy.
Amrik S Kang, Radhika Dalal, Mingcheng Li, and 23 othersAmrik S Kang, Radhika Dalal, Mingcheng Li, Anupam Anand Ojha, Sujata Walunj, Caitlin E Cornell, Ruyan Rahnama, Abhilash Barpanda, Sanjana Prudhvi, Trishna S Patel, Mark Aspinall-O’Dea, Beth Walker, Clare Adams, Veronica Steri, Paul Phojanakong, Juan Antonio Camara Serrano, Hua Li, Yan Zeng, Jose Rivera, Daniel A Fletcher, Benjamin J Huang, Sonya M Hanson, Pilar Cossio, Tanja Kortemme, Justin Eyquem, Arun P Wiita fewer authors
University of California, San Francisco; Flatiron Institute; University of California, Berkeley; and 3 othersUniversity of California, San Francisco; Flatiron Institute; University of California, Berkeley; Charles River Laboratories England; Parker Institute for Cancer Immunotherapy; Biohub fewer institutions